Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_assertion type Assertion NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_head.
- NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_assertion description "[Furthermore, we compared GPX3 level of expression and methylation status in aggressive phenotype inflammatory breast cancer (IBC) versus non-IBC invasive ductal carcinoma (IDC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_provenance.
- NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_assertion evidence source_evidence_literature NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_provenance.
- NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_assertion SIO_000772 24790704 NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_provenance.
- NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_assertion wasDerivedFrom befree-20150227 NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_provenance.
- NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_assertion wasGeneratedBy ECO_0000203 NP433421.RAf0UTFVugYHGjho6UPBn00fyZeOqCOf6_FlkPYjeCmL8130_provenance.